Found: 4
Select item for more details and to access through your institution.
Linagliptin as add‐on to empagliflozin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two‐part, randomized, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 1, p. 136, doi. 10.1111/dom.13496
- By:
- Publication type:
- Article
Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4‐week, double‐blind, randomized, placebo‐controlled phase 2 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2190, doi. 10.1111/dom.13351
- By:
- Publication type:
- Article
Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study.
- Published in:
- Hypertension Research, 2017, v. 40, n. 3, p. 251, doi. 10.1038/hr.2016.124
- By:
- Publication type:
- Article
Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 2, p. 863, doi. 10.1007/s13300-018-0385-5
- By:
- Publication type:
- Article